Summary |
|
|||||||||||||
Variant origin |
|
|||||||||||||
Variant description |
|
|||||||||||||
Phenotypes |
View phenotypes and curated references for all genotypes (concatenated display).
|
|||||||||||||
Notes |
Mapping and Phenotype information for this QTL, its variants and associated markersJ:30526The percentage of circulating CD4+ T Cells in NOD/Smrf mice is 40-50% greater then NON/Lt mice, enabling the investigation of how this quantitative phenotype segregates in a BC1 population (NON/Lt x NOD/Smrf)F1 x NOD/Smrf and in an F2 population (NON/Lt x NOD/Smrf)F1 x (NON/Lt x NOD/Smrf)F1. Statistical analysis using t-tests showed a significant correlation of circulating CD4+ T cells with the mouse Chromosome 9 marker D9Mit12 in both male and female segregants. The gene or genetic region responsible for this phenotype is termed Tlf (T lymphocyte frequency) Importantly, the authors show a correlation of Tlf with diabetic incidence as expressed by NON/Lt and NOD/Smrf mice suggesting that Tlf may in fact be the mouse Chromosome 9 locus Idd2. J:49676The author refines the mapping of a region which governs the unusually high fraction of circulating T lymphocytes in the nonobese diabetic (NOD) mice. Linkage analysis of (NON/Lt x NOD/Smrf)F1 x NOD/Smrf, and (NOD/Smrf x NON/Lt)F1 x NOD/Smrf progeny, and F2 animals from F1 crosses indicates that the phenotype is associated with two regions of mouse Chromosme 9. One region, Tlf, was placed between D9Mit66 (15 cM) and D9Mit2 (17 cM). The second region, Tlf2, was placed distal near D9Mit71 (29 cM). |
|||||||||||||
References |
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 12/10/2024 MGI 6.24 |
|
|